Cargando…

Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma

BACKGROUND: For therapeutic monitoring and pharmacokinetic studies of lenalidomide (LND), the potent drug for treatment of multiple myeloma (MM), a specific antibody was required for the development of a sensitive immunoassay system for the accurate determination of LND in plasma. RESULTS: In this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darwish, Ibrahim A, Alzoman, Nourh Z, Abuhejail, Reem M, El-Samani, Tilal E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496571/ https://www.ncbi.nlm.nih.gov/pubmed/23101764 http://dx.doi.org/10.1186/1752-153X-6-125

Ejemplares similares

Development of Two Novel One-Step and Green Microwell Spectrophotometric Methods for High-Throughput Determination of Ceritinib, a Potent Drug for Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
por: Abuhejail, Reem M., et al.
Publicado: (2023)

Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing
por: Abuhejail, Reem M., et al.
Publicado: (2023)

A highly sensitive fluorimetric method for determination of lenalidomide in its bulk form and capsules via derivatization with fluorescamine
por: Darwish, Ibrahim A, et al.
Publicado: (2012)

Preparation and Characterization of Two Immunogens and Production of Polyclonal Antibody with High Affinity and Specificity for Darunavir
por: Darwish, Ibrahim A., et al.
Publicado: (2020)

Synthesis of hapten, generation of specific polyclonal antibody and development of ELISA with high sensitivity for therapeutic monitoring of crizotinib
por: Al-Shehri, Mona M., et al.
Publicado: (2019)

Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
por: Schrand, Brett, et al.
Publicado: (2018)

Author Correction: Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
por: Schrand, Brett, et al.
Publicado: (2021)

HAPTEN-SPECIFIC TOLERANCE : PREFERENTIAL DEPRESSION OF THE HIGH AFFINITY ANTIBODY RESPONSE
por: Davie, Joseph M., et al.
Publicado: (1972)

Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulins
por: Schieferdecker, Aneta, et al.
Publicado: (2016)

Requirement of a Blocking Step in Affinity Purification of Polyclonal Antibodies
por: Hamzehlou, Sepideh, et al.
Publicado: (2015)

A New Highly Selective and Specific Anti-puerarin polyclonal Antibody for Determination of Puerarin Using a Mannich Reaction Hapten Conjugate
por: Udomsin, Orapin, et al.
Publicado: (2017)

Novel haptens and monoclonal antibodies with subnanomolar affinity for a classical analytical target, ochratoxin A
por: López-Puertollano, Daniel, et al.
Publicado: (2018)

T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten- specific cytolytic T lymphocytes
Publicado: (1980)

A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse
por: Torres, Oscar B., et al.
Publicado: (2015)

Novel Polyclonal Antibody Raised against Tetrodotoxin Using Its Haptenic Antigen Prepared from 4,9-anhydrotetrodotoxin Reacted with 1,2-Ethaneditiol and Further Reacted with Keyhole Limpet Hemocyanin
por: Sato, Shigeru, et al.
Publicado: (2019)

Design and Characterization of a Novel Hapten and Preparation of Monoclonal Antibody for Detecting Atrazine
por: Xu, Lingyuan, et al.
Publicado: (2022)

Preparation and Characterization of a Polyclonal Antibody against Brominated Protein
por: Kambayashi, Yasuhiro, et al.
Publicado: (2009)

CARRIER FUNCTION IN ANTI-HAPTEN ANTIBODY RESPONSES : IV. EXPERIMENTAL CONDITIONS FOR THE INDUCTION OF HAPTEN-SPECIFIC TOLERANCE OR FOR THE STIMULATION OF ANTI-HAPTEN ANAMNESTIC RESPONSES BY "NONIMMUNOGENIC" HAPTEN-POLYPEPTIDE CONJUGATES
por: Katz, David H., et al.
Publicado: (1971)

COVID-19 impact on pharmacy education in Saudi Arabia: Challenges and opportunities
por: Almetwazi, Mansour, et al.
Publicado: (2020)

QUANTITATIVE INVESTIGATIONS OF IDIOTYPIC ANTIBODIES : IV. INHIBITION BY SPECIFIC HAPTENS OF THE REACTION OF ANTI-HAPTEN ANTIBODY WITH ITS ANTI-IDIOTYPIC ANTIBODY
por: Brient, Bruce W., et al.
Publicado: (1970)

Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens
por: Reddy, Sreenivasulu B., et al.
Publicado: (2015)

Generation of High Affinity Anti-Peptide Polyclonal Antibodies Recognizing Goat α(s1)-Casein
por: Mohsin, Aliah Zannierah, et al.
Publicado: (2020)

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma
por: Lund, Johan, et al.
Publicado: (2018)

Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle
por: Dye, John M., et al.
Publicado: (2016)

CELLULAR HETEROGENEITY IN THE PRODUCTION OF AN ANTI-HAPTEN ANTIBODY
por: Mäkelä, O.
Publicado: (1967)

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment
por: Dimopoulos, M A, et al.
Publicado: (2017)

HAPTEN-CARRIER RELATIONSHIPS OF ISOANTIGENS : A MODEL FOR IMMUNOLOGICAL MATURATION BASED ON THE CONVERSION OF HAPTENS TO CARRIERS BY ANTIBODY
por: McBride, Raymond A., et al.
Publicado: (1970)

PERSISTENCE OF HAPTEN-ANTIBODY COMPLEXES IN THE CIRCULATION OF IMMUNIZED ANIMALS AFTER A SINGLE INTRAVENOUS INJECTION OF HAPTEN
por: Schmidt, Donald H., et al.
Publicado: (1974)

Structural Analysis of Anti-Hapten Antibodies to Identify Long-Range Structural Movements Induced by Hapten Binding
por: Al Qaraghuli, Mohammed M., et al.
Publicado: (2021)

Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
por: Han, Xiangning, et al.
Publicado: (2023)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
por: van de Donk, Niels WCJ, et al.
Publicado: (2012)

Lenalidomide in the Treatment of Lymphoproliferative Disorders and Multiple Myeloma
por: Liberati, Anna Marina, et al.
Publicado: (2013)

Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer
por: Darwish, Ibrahim A., et al.
Publicado: (2023)

Preparation of polyclonal anti-Schistosoma mansoni cysteine protease antibodies for early diagnosis
por: Farid, Alyaa
Publicado: (2023)

A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids
por: Torres, Oscar B., et al.
Publicado: (2018)

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
por: Dimopoulos, Meletios A., et al.
Publicado: (2018)

Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens
por: Botta, Cirino, et al.
Publicado: (2021)

Development and Validation of Green and High-Throughput Microwell Spectrophotometric Assay for the Determination of Selective Serotonin Reuptake Inhibitors in Their Pharmaceutical Dosage Forms
por: Darwish, Ibrahim A., et al.
Publicado: (2023)

Development of Green and High Throughput Microplate Reader-Assisted Universal Microwell Spectrophotometric Assay for Direct Determination of Tyrosine Kinase Inhibitors in Their Pharmaceutical Formulations Irrespective the Diversity of Their Chemical Structures
por: Darwish, Ibrahim A., et al.
Publicado: (2023)

Development of a Green Microwell Spectrofluorimetric Assay with High Analytical Throughput for the Determination of Selective Serotonin Reuptake Inhibitors in Pharmaceutical Dosage Forms and Plasma
por: Alzoman, Nourah Z., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_97ub4g1cvrrs3bk2onddd9qaml